leukemia
Pharmacotyping Links Childhood Leukemia Subtypes to Treatment Response
With drug sensitivity and genomic profiles on acute lymphoblastic leukemia cells, coupled with patient data, researchers saw pharmacotypes related to treatment response and outcomes.
SeekIn Receives CE-IVD Mark for Leukemia Cancer Mutation Detection Kit
The company's PanCanSeek test uses whole-genome sequencing to analyze bone marrow samples from leukemia patients, replacing a variety of more targeted technologies.
Envisagenics, Cancer Research UK, Queen Mary University Collaborate on AML Drug R&D
Cold Spring Harbor spinout Envisagenics will apply its AI technology to multiomics data in pursuit of new therapies for acute myeloid leukemia and other hematopoietic cancers.
Polygenic Risk Score Shows Potential in Personalizing Chemotherapy for Pediatric AML Patients
Premium
At ASH's annual meeting, researchers reported that patients with low scores on a 10-SNP test fared better when they got clofarabine plus the standard 7+3 course of chemo.
Aussie Variant Classification Effort Aims to Reduce Uncertainty in Hereditary Blood Cancer Diagnosis
Premium
The researchers hope to determine whether tens of thousands of variants in RUNX1 and GATA2 increase predisposition to blood cancers.